In vivo gene delivery mediated by non-viral vectors for cancer therapy
R Mohammadinejad, A Dehshahri… - Journal of Controlled …, 2020 - Elsevier
Gene therapy by expression constructs or down-regulation of certain genes has shown great
potential for the treatment of various diseases. The wide clinical application of nucleic acid …
potential for the treatment of various diseases. The wide clinical application of nucleic acid …
Poly (amidoamine)(PAMAM) dendrimer mediated delivery of drug and pDNA/siRNA for cancer therapy
J Li, H Liang, J Liu, Z Wang - International journal of pharmaceutics, 2018 - Elsevier
Abstract Poly (amidoamine)(PAMAM) dendrimers are well-defined, highly branched
macromolecules with numerous active amine groups on the surface. Because of their …
macromolecules with numerous active amine groups on the surface. Because of their …
Emerging therapies for hepatocellular carcinoma (HCC)
E Chakraborty, D Sarkar - Cancers, 2022 - mdpi.com
Simple Summary Primary liver cancer, also known as Hepatocellular carcinoma (HCC), is
considered to be a major global health challenge. Due to delays in diagnosis at early …
considered to be a major global health challenge. Due to delays in diagnosis at early …
Chitosan for gene delivery: Methods for improvement and applications
D Chuan, T Jin, R Fan, L Zhou, G Guo - Advances in colloid and interface …, 2019 - Elsevier
Gene therapy is a promising strategy for treating challenging diseases. The successful
delivery of genes is a critical step for gene therapy. However, concerns about …
delivery of genes is a critical step for gene therapy. However, concerns about …
Chitosan-based advanced materials for docetaxel and paclitaxel delivery: Recent advances and future directions in cancer theranostics
Paclitaxel (PTX) and docetaxel (DTX) are key members of taxanes with high anti-tumor
activity against various cancer cells. These chemotherapeutic agents suffer from a number of …
activity against various cancer cells. These chemotherapeutic agents suffer from a number of …
Galactose engineered nanocarriers: Hopes and hypes in cancer therapy
M Fatima, R Karwasra, WH Almalki, A Sahebkar… - European Polymer …, 2023 - Elsevier
For specific targeting of cancer tissues, adequate information about the cancer tissue
environment, cancer cell pathology, and available methods and limits of such methods is …
environment, cancer cell pathology, and available methods and limits of such methods is …
[HTML][HTML] Current status of nanomaterial-based treatment for hepatocellular carcinoma
Cancer continues to be the leading cause of death worldwide. Hepatocellular carcinoma
(HCC), a prominent form of liver cancer, is the second leading cause of cancer-related …
(HCC), a prominent form of liver cancer, is the second leading cause of cancer-related …
Ligand-based targeted therapy: a novel strategy for hepatocellular carcinoma
M Li, W Zhang, B Wang, Y Gao, Z Song… - International Journal of …, 2016 - Taylor & Francis
Hepatocellular carcinoma (HCC) is the most common primary liver cancer with high
morbidity and mortality worldwide. Chemotherapy is recommended to patients with …
morbidity and mortality worldwide. Chemotherapy is recommended to patients with …
Therapeutic strategies for miRNA delivery to reduce hepatocellular carcinoma
Malignancies of hepatocellular carcinoma (HCC) are rapidly spreading and commonly fatal.
Like most cancers, the gene expression patterns in HCC vary significantly from patient to …
Like most cancers, the gene expression patterns in HCC vary significantly from patient to …
Polysaccharide-based nanoparticles for gene delivery
Nanoparticles based on nanotechnology and biotechnology have emerged as efficient
carriers for various biopharmaceutical agents including proteins and genes. In particular …
carriers for various biopharmaceutical agents including proteins and genes. In particular …